Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
14 04 2023
Historique:
medline: 11 4 2023
entrez: 7 4 2023
pubmed: 8 4 2023
Statut: ppublish

Résumé

Macrophages are central orchestrators of the tissue response to injury, with distinct macrophage activation states playing key roles in fibrosis progression and resolution. Identifying key macrophage populations found in human fibrotic tissues could lead to new treatments for fibrosis. Here, we used human liver and lung single-cell RNA sequencing datasets to identify a subset of

Identifiants

pubmed: 37027478
doi: 10.1126/sciimmunol.add8945
doi:

Substances chimiques

Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1
Transforming Growth Factor beta1 0
Interleukin-17 0
FABP5 protein, human 0
Fatty Acid-Binding Proteins 0
GPNMB protein, human 0
Membrane Glycoproteins 0
Trem2 protein, mouse 0
Receptors, Immunologic 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadd8945

Auteurs

Thomas Fabre (T)

Pfizer Inc., Cambridge, MA, USA.

Shoh Asano (S)

Pfizer Inc., Cambridge, MA, USA.

Kathryn Bound (K)

Pfizer Inc., Cambridge, MA, USA.

Matthew P Lech (MP)

Pfizer Inc., Cambridge, MA, USA.

Marc H Wadsworth (MH)

Pfizer Inc., Cambridge, MA, USA.

Xiao Chen (X)

Pfizer Inc., Cambridge, MA, USA.

Chang Wang (C)

Pfizer Inc., Cambridge, MA, USA.

Ju Wang (J)

Pfizer Inc., Cambridge, MA, USA.

James McMahon (J)

Pfizer Inc., Cambridge, MA, USA.

Franklin Schlerman (F)

Pfizer Inc., Cambridge, MA, USA.

Alexis White (A)

Pfizer Inc., Cambridge, MA, USA.

Kellie M Kravarik (KM)

Pfizer Inc., Cambridge, MA, USA.

Andrew J Fisher (AJ)

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Lee A Borthwick (LA)

Newcastle Fibrosis Research Group, Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Kevin M Hart (KM)

Pfizer Inc., Cambridge, MA, USA.

Neil C Henderson (NC)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Centre for Inflammation Research, the Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Thomas A Wynn (TA)

Pfizer Inc., Cambridge, MA, USA.

Ken Dower (K)

Pfizer Inc., Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH